On June 1, 2022 Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, reported that management will present at the following investor conferences (Press release, Compugen, JUN 1, 2022, View Source [SID1234615392]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event: Jefferies Healthcare Conference, New York City
Date: Wednesday June 8, 2022
Fireside Chat Time: 1:30PM ET
A live webcast will be accessible on the Investor Relations section of the Compugen website at www.cgen.com. A replay will also be available following the live event.
Event: JMP Securities Life Sciences Conference, New York City
Date: Wednesday, June 15, 2022
Fireside Chat Time: 9:00AM ET
A live webcast will be accessible on the Investor Relations section of the Compugen website at www.cgen.com. A replay will also be available following the live event.